Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma.

Lim KJC, Tan M, Parrondo R, Chhabra S, Dooley K, De Menezes Silva Corraes A, Carabenciov D, Gertz M, Hwa L, Haily S, Kapoor P, Kourelis T, Warsame R, Cook J, Binder M, Bergsagel PL, Yadav U, Wiedmeier-Nutor E, Geyer S, Ailawadhi S, Fonseca R, Kumar S, Zekeridou A, Lin Y

Open source

DOI: 10.1038/s41408-025-01441-3
Published: 2025 Dec 31
Container: Blood cancer journal
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41408-025-01441-3,
  title = {Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma.},
  author = {Lim KJC and Tan M and Parrondo R and Chhabra S and Dooley K and De Menezes Silva Corraes A and Carabenciov D and Gertz M and Hwa L and Haily S and Kapoor P and Kourelis T and Warsame R and Cook J and Binder M and Bergsagel PL and Yadav U and Wiedmeier-Nutor E and Geyer S and Ailawadhi S and Fonseca R and Kumar S and Zekeridou A and Lin Y},
  year = {2025},
  journal = {Blood cancer journal},
  doi = {10.1038/s41408-025-01441-3},
  url = {https://doi.org/10.1038/s41408-025-01441-3}
}

RIS

TY  - JOUR
TI  - Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma.
AU  - Lim KJC
AU  - Tan M
AU  - Parrondo R
AU  - Chhabra S
AU  - Dooley K
AU  - De Menezes Silva Corraes A
AU  - Carabenciov D
AU  - Gertz M
AU  - Hwa L
AU  - Haily S
AU  - Kapoor P
AU  - Kourelis T
AU  - Warsame R
AU  - Cook J
AU  - Binder M
AU  - Bergsagel PL
AU  - Yadav U
AU  - Wiedmeier-Nutor E
AU  - Geyer S
AU  - Ailawadhi S
AU  - Fonseca R
AU  - Kumar S
AU  - Zekeridou A
AU  - Lin Y
PY  - 2025
JO  - Blood cancer journal
DO  - 10.1038/s41408-025-01441-3
UR  - https://doi.org/10.1038/s41408-025-01441-3
ER  -

APA

KJC, L., M, T., R, P., S, C., K, D., A, D. M. S. C., D, C., M, G., L, H., S, H., P, K., T, K., R, W., J, C., M, B., PL, B., U, Y., E, W., S, G., S, A., R, F., S, K., A, Z., & Y, L. (2025). Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma.. Blood cancer journal. https://doi.org/10.1038/s41408-025-01441-3

Source records

pubmed · retrieved 2026-09-26T22:44:01.215Z
europe-pmc · retrieved 2026-09-26T22:44:01.231Z
doaj · retrieved 2026-09-26T22:44:01.233Z